Department of Health
and Human Services (HHS)
and Human Services (HHS)
May 6, 2020
The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-18-721 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)." Specifically, the last receipt date has been changed to June 30, 2020 and the new expiration date for this FOA will be July 1, 2020. Changes to the FOA are shown below in bold italics.
Currently Reads:
Part 1. Overview Information
Key Dates:
| Application Due Date(s) |
May 30, 2018; May 28, 2019; May 26, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
|
Expiration Date |
May 27, 2020 |
Modified to Read:
Part 1. Overview Information
Key Dates:
| Application Due Date(s) |
May 30, 2018; May 28, 2019; June 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Expiration Date | July 1, 2020 |
All other aspects of this FOA remain unchanged.
Please direct all inquiries to:
Shardell Spriggs, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-443-8189
Email: [email protected]